Enabling the next-generation of Growth Factors
using Plant Biotechnology
PLANTS AS BIOFACTORIES OF ACTIVES
CORE Biogenesis has revolutionized the production of active compounds with its patented whole-plant bioproduction system, enabling stable and scalable expression of high-performance proteins and peptides. Leveraging advanced biotechnology, our scientists can covalently fuse these proteins to Oleosomes—natural oil reservoirs found within plant seeds.
This innovative fusion not only enhances the stability of the proteins but also ensures superior delivery to the skin, outperforming "naked" recombinant proteins produced by traditional methods. CORE Biogenesis is redefining the future of active ingredients in personal care.
"WE HAVE PIONEERED OUR CUTTING-EDGE PLANT BIOFACTORY TECHNOLOGY INITIALLY SUPPLYING BIOACTIVES TO LEADING ACADEMIC INSTITUTIONS IN LIFE SCIENCES. TODAY WE PROUDLY OFFER A SCALABLE, RELIABLE SOLUTION FOR ACTIVES IN PERSONAL CARE "
Chief Scientific Officer Dr. Chouaib Meziadi PhD on the technology platform behind CORE Biogenesis.
"WE HAVE PIONEERED OUR CUTTING-EDGE PLANT BIOFACTORY TECHNOLOGY INITIALLY SUPPLYING BIOACTIVES TO LEADING ACADEMIC INSTITUTIONS IN LIFE SCIENCES. TODAY WE PROUDLY OFFER A SCALABLE, RELIABLE SOLUTION FOR ACTIVES IN PERSONAL CARE "
Chief Scientific Officer Dr. Chouaib Meziadi PhD on the technology platform behind CORE Biogenesis.
EGF fused to Oleosomes by CORE Biogenesis retains 93% of its concentration after 12 months, compared to only 8% when EGF is used alone.
FGF-2 fused to Oleosomes by CORE Biogenesis retains 97% of its concentration after 12 months, compared to only 13% when FGF-2 is used alone.
CORE BIOGENESIS © - Privacy Policy - Terms of Use